BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10699467)

  • 1. Opposing changes in N-acetylglucosaminyltransferase-V and -III during the cell cycle and all-trans retinoic acid treatment of hepatocarcinoma cell line.
    Guo HB; Jiang AL; Ju TZ; Chen HL
    Biochim Biophys Acta; 2000 Feb; 1495(3):297-307. PubMed ID: 10699467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased susceptibility to apoptosis of human hepatocarcinoma cells transfected with antisense N-acetylglucosaminyltransferase V cDNA.
    Guo HB; Liu F; Chen HL
    Biochem Biophys Res Commun; 1999 Oct; 264(2):509-17. PubMed ID: 10529394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle-dependent regulation of N-acetylglucosaminyltransferase-III in a human colon cancer cell line, Colo201.
    Kang R; Ikeda Y; Miyoshi E; Wang W; Li W; Ihara Y; Sheng Y; Taniguchi N
    Arch Biochem Biophys; 2000 Feb; 374(1):52-8. PubMed ID: 10640395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans-retinoic acid intensifies endoplasmic reticulum stress in N-acetylglucosaminyltransferase V repressed human hepatocarcinoma cells by perturbing homocysteine metabolism.
    Xu YY; Guan DY; Yang M; Wang H; Shen ZH
    J Cell Biochem; 2010 Feb; 109(3):468-77. PubMed ID: 19960509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
    Guo HB; Liu F; Zhao JH; Chen HL
    J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in glycosyltransferases during myeloid and monocytoid differentiation of HL-60 cells.
    Liu AH; Liu F; Li Z; Gu JX; Chen HL
    Cell Biol Int; 1998; 22(7-8):545-50. PubMed ID: 10452822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis induced by all-trans retinoic acid in N-acetylglucosaminyltransferase V repressed human hepatocarcinoma cells is mediated through endoplasmic reticulum stress.
    Xu YY; Lu Y; Fan KY; Shen ZH
    J Cell Biochem; 2007 Feb; 100(3):773-82. PubMed ID: 17031849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-trans-retinoic acid modulates ICAM-1 N-glycan composition by influencing GnT-III levels and inhibits cell adhesion and trans-endothelial migration.
    Chen C; Diao D; Guo L; Shi M; Gao J; Hu M; Yu M; Qian L; Guo N
    PLoS One; 2012; 7(12):e52975. PubMed ID: 23300837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of H-ras and v-sis overexpression on N-acetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells.
    Guo HB; Zhang QS; Chen HL
    J Cancer Res Clin Oncol; 2000 May; 126(5):263-70. PubMed ID: 10815761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking of N-acetylglucosaminyltransferase V induces cellular endoplasmic reticulum stress in human hepatocarcinoma 7,721 cells.
    Fang H; Huang W; Xu YY; Shen ZH; Wu CQ; Qiao SY; Xu Y; Yu L; Chen HL
    Cell Res; 2006 Jan; 16(1):82-92. PubMed ID: 16467879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered β1,6-GlcNAc and bisecting GlcNAc-branched N-glycan on integrin β1 are associated with early spontaneous miscarriage in humans.
    Zhang M; Wang M; Gao R; Liu X; Chen X; Geng Y; Ding Y; Wang Y; He J
    Hum Reprod; 2015 Sep; 30(9):2064-75. PubMed ID: 26109616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147.
    Fan J; Wang S; Yu S; He J; Zheng W; Zhang J
    Glycoconj J; 2012 Aug; 29(5-6):323-34. PubMed ID: 22736280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of mouse embryo fibroblast N-acetylglucosaminyltransferase V stimulates alpha5beta1 integrin expression mediated by the protein kinase C signaling pathway.
    Guo HB; Lee I; Bryan BT; Pierce M
    J Biol Chem; 2005 Mar; 280(9):8332-42. PubMed ID: 15615721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.
    Pinho SS; Reis CA; Paredes J; Magalhães AM; Ferreira AC; Figueiredo J; Xiaogang W; Carneiro F; Gärtner F; Seruca R
    Hum Mol Genet; 2009 Jul; 18(14):2599-608. PubMed ID: 19403558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the basal activity of phosphatidylinositol-3-kinase/protein kinase B signaling pathway in human hepatocarcinoma cells.
    Guo HB; Shen ZH; Huang CX; Ma J; Huang Y; Chen HL
    Glycoconj J; 2000 May; 17(5):315-22. PubMed ID: 11261840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of UDP-N-acetylglucosamine: alphamannoside beta1,6 N-acetylglucosaminyltransferase is an early event in hepatocarcinogenesis.
    Ito Y; Miyoshi E; Sakon M; Takeda T; Noda K; Tsujimoto M; Ito S; Honda H; Takemura F; Wakasa K; Monden M; Matsuura N; Taniguchi N
    Int J Cancer; 2001 Mar; 91(5):631-7. PubMed ID: 11267972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of cell cycle related gene expression in cultured immortalized human lens epithelial cell].
    Wu M; Li S; Zeng J; Gao J; Liu Y
    Zhonghua Yan Ke Za Zhi; 2002 Jun; 38(6):367-71. PubMed ID: 12139816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis.
    Miyoshi E; Nishikawa A; Ihara Y; Gu J; Sugiyama T; Hayashi N; Fusamoto H; Kamada T; Taniguchi N
    Cancer Res; 1993 Sep; 53(17):3899-902. PubMed ID: 8240532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in N -acetylglucosaminyltransferase activities and glycan structure in tissue and bile glycoproteins from extrahepatic bile duct carcinoma.
    Jin XL; Liu HB; Zhang Y; Wang BS; Chen HL
    Glycoconj J; 2004; 20(6):399-406. PubMed ID: 15238704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.
    Teixeira C; Pratt MA
    Mol Endocrinol; 1997 Aug; 11(9):1191-202. PubMed ID: 9259311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.